PHARMA SERVICES GHEYSENS (Private limited company)
PHARMA SERVICES GHEYSENS is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0841.464.310. It was founded on 01-12-2011. Its registered office is in Kortrijk. Its main activity is: Financial service activities, except insurance and pension funding. Its annual accounts for 2025 report equity of € 430 008 and a profit of € 23 241. These accounts report 1 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 21-10-2026.
Company information
Key figures of PHARMA SERVICES GHEYSENS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 23 241-43 % | € 40 779-8 % | € 44 553+6 % | € 42 182 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 430 008+6 % | € 406 768+11 % | € 365 989+14 % | € 321 435 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 1 731 176+7 % | € 1 620 525+7 % | € 1 512 742+1 % | € 1 499 045 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 176 123+5 % | € 167 721-1 % | € 168 832-3 % | € 173 331 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 1-9 % | 1.1+10 % | 10 % | 1 |
Financial estimate
- 1 Subsidiaries
- 1 Board links
Similar companies
Other companies in the same activity in Kortrijk.
| Company | Town |
|---|---|
| WIENERBERGER | 8500 Kortrijk |
| Vandelanotte ++ | 8500 Kortrijk |
| Elk Zijn Huis | 8500 Kortrijk |
| KORAMIC DEVELOPMENT PROJECTS | 8500 Kortrijk |
| B.M.H. | 8500 Kortrijk |
| TrustCapital | 8500 Kortrijk |
| Koramic Real Estate | 8500 Kortrijk |
| Maatschappij voor Katholieke Vlaamse Werken | 8500 Kortrijk |
Frequently asked questions
Is PHARMA SERVICES GHEYSENS still active? Yes. The Crossroads Bank for Enterprises lists PHARMA SERVICES GHEYSENS as active.
What is the VAT number of PHARMA SERVICES GHEYSENS? The VAT number of PHARMA SERVICES GHEYSENS is BE 0841.464.310.
When was PHARMA SERVICES GHEYSENS founded? PHARMA SERVICES GHEYSENS was founded on 01-12-2011.
What is the address of PHARMA SERVICES GHEYSENS? The current registered office of PHARMA SERVICES GHEYSENS is Lange Munteplein(Kor) 9, 8500 Courtrai.
When did PHARMA SERVICES GHEYSENS last file annual accounts? The latest annual accounts of PHARMA SERVICES GHEYSENS were filed on 16-04-2026.
Does PHARMA SERVICES GHEYSENS file its annual accounts on time? Yes. PHARMA SERVICES GHEYSENS filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does PHARMA SERVICES GHEYSENS have? PHARMA SERVICES GHEYSENS employs 1 full-time equivalents according to its most recent annual accounts.
Is PHARMA SERVICES GHEYSENS financially healthy? Addrly gives PHARMA SERVICES GHEYSENS a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is PHARMA SERVICES GHEYSENS profitable? The annual accounts of PHARMA SERVICES GHEYSENS for 2025 show a profit of € 23 241.
What is the equity of PHARMA SERVICES GHEYSENS? The equity of PHARMA SERVICES GHEYSENS was € 430 008 at the close of the 2025 financial year.
Who are the directors of PHARMA SERVICES GHEYSENS? The annual accounts of PHARMA SERVICES GHEYSENS record 1 mandate. The name, role and dates are visible with a free account.
Can PHARMA SERVICES GHEYSENS receive Peppol e-invoices? Yes. PHARMA SERVICES GHEYSENS is registered on the Peppol network and can receive structured electronic invoices.
What does PHARMA SERVICES GHEYSENS do? The main activity of PHARMA SERVICES GHEYSENS is: Financial service activities, except insurance and pension funding.